A Study of CTX-009 (ABL001) in Combination With Irinotecan or Paclitaxel in Advanced or Metastatic Solid Tumor Patients

NCT04492033 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

41

Enrollment

INDUSTRY

Sponsor class

Stopped Change of Development Plan

Conditions

P1b: Advanced Solid Tumors
P2: Biliary Tract Cancer

Interventions

DRUG: CTX-009 (ABL001)
DRUG: Paclitaxel
DRUG: Irinotecan

Sponsor

Handok Inc.

Collaborators

[object Object]
[object Object]